SAT-161 - Obeticholic acid, a FXR agonist, inhibits the cancerogenic potential of primary human cholangiocarcinoma (CCA) cells cultures

Bibliographic Details
Title: SAT-161 - Obeticholic acid, a FXR agonist, inhibits the cancerogenic potential of primary human cholangiocarcinoma (CCA) cells cultures
Authors: Matteo, S.D., Nevi, L., Constantini, D., Colantonio, M., Giulitti, F., Napoletano, C., Safarikia, S., Manzi, E., Rose, A.M.D., Melandro, F., Bragazzi, M., Berloco, P.B., Giuliante, F., Carpino, G., Cardinale, V., Gaudio, E., Alvaro, D.
Source: In Journal of Hepatology April 2018 68 Supplement 1:S677-S679
Database: ScienceDirect
More Details
ISSN:01688278
DOI:10.1016/S0168-8278(18)31614-3
Published in:Journal of Hepatology
Language:English